230 related articles for article (PubMed ID: 28657202)
1. Assessing Pharmacodynamic Interactions in Mice Using the Multistate Tuberculosis Pharmacometric and General Pharmacodynamic Interaction Models.
Chen C; Wicha SG; de Knegt GJ; Ortega F; Alameda L; Sousa V; de Steenwinkel JEM; Simonsson USH
CPT Pharmacometrics Syst Pharmacol; 2017 Nov; 6(11):787-797. PubMed ID: 28657202
[TBL] [Abstract][Full Text] [Related]
2. Bactericidal action of pulsed exposure to rifampicin, ethambutol, isoniazid & pyrazinamide on Mycobacterium tuberculosis in vitro.
Paramasivan CN; Herbert D; Prabhakar R
Indian J Med Res; 1993 Jul; 97():145-50. PubMed ID: 8406638
[TBL] [Abstract][Full Text] [Related]
3. [Experimental evidence for Mycobacterium tuberculosis persistence in M. tuberculosis-infected H37RV mice in the treatment with 3 first-line drugs (rifampicin, isoniazid, pyrazinamide)].
Smirnova TG; Chernousova LN; Andreevskaia SN; Nikolaeva GM
Probl Tuberk Bolezn Legk; 2004; (3):32-7. PubMed ID: 15338898
[TBL] [Abstract][Full Text] [Related]
4. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Dickinson JM; Aber VR; Mitchison DA
Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
[TBL] [Abstract][Full Text] [Related]
5. The multistate tuberculosis pharmacometric model: a semi-mechanistic pharmacokinetic-pharmacodynamic model for studying drug effects in an acute tuberculosis mouse model.
Chen C; Ortega F; Rullas J; Alameda L; Angulo-Barturen I; Ferrer S; Simonsson US
J Pharmacokinet Pharmacodyn; 2017 Apr; 44(2):133-141. PubMed ID: 28205025
[TBL] [Abstract][Full Text] [Related]
6. The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.
Iacobino A; Giannoni F; Pardini M; Piccaro G; Fattorini L
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31010861
[TBL] [Abstract][Full Text] [Related]
7. Tuberculosis Drug Development: History and Evolution of the Mechanism-Based Paradigm.
Chakraborty S; Rhee KY
Cold Spring Harb Perspect Med; 2015 Apr; 5(8):a021147. PubMed ID: 25877396
[TBL] [Abstract][Full Text] [Related]
8. Combination chemotherapy with the nitroimidazopyran PA-824 and first-line drugs in a murine model of tuberculosis.
Nuermberger E; Rosenthal I; Tyagi S; Williams KN; Almeida D; Peloquin CA; Bishai WR; Grosset JH
Antimicrob Agents Chemother; 2006 Aug; 50(8):2621-5. PubMed ID: 16870750
[TBL] [Abstract][Full Text] [Related]
9. Translational Model-Informed Approach for Selection of Tuberculosis Drug Combination Regimens in Early Clinical Development.
Susanto BO; Wicha SG; Hu Y; Coates ARM; Simonsson USH
Clin Pharmacol Ther; 2020 Aug; 108(2):274-286. PubMed ID: 32080839
[TBL] [
